Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Improved survival outcomes in angioimmunoblastic T-cell lymphoma linked to care at academic cancer centers: A national cancer database study.

Vanessa Velazquez, Leyla Bojanini, Erin Kaser, Daniel Rosas, Victor Mendiola, Gabriel Giraldo, Qianqian Liu, Joel Michalek, Supreet Kaur, Adolfo Diaz Duque

Blood (2025) 146 (Supplement 1): 2763.

https://doi.org/10.1182/blood-2025-2763

Published: 2025

Journal Articles

Facility type and survival outcomes in extranodal NK/T-cell lymphoma, nasal type: A national cancer database analysis

Gabriel Giraldo Ospino, Leyla Bojanini, Erin Kaser, Victor Mendiola, Vanessa Velazquez, Daniel Rosas, Qianqian Liu, Joel Michalek, Supreet Kaur, Adolfo Diaz Duque

Blood (2025) 146 (Supplement 1): 8022.

https://doi.org/10.1182/blood-2025-8022

Published: 2025

Journal Articles

Cardiovascular safety profile of CD20 × CD3 bispecific antibodies compared to immune-checkpoint inhibitors: A faers analysis, 2014–2025

Manzer Ali, Zayd Parekh, Rohan Mylavarapu, Saad Rashid, Daniel Rosas, Muhammad Awais Bin Abdul Malik, Hanzala Jehangir, Rajesh Thirumaran, Aftab Ahmed, Mohammed AL-Jumayli, Kirti Arora, Kevin Bera, Bolivia Fernandes

Blood (2025) 146 (Supplement 1): 7657.

https://doi.org/10.1182/blood-2025-7657

Published: 2025

Journal Articles

A national lens on follicular lymphoma: Academic care linked to improved survival in 158,000 patients

Daniel Rosas, Leyla Bojanini, Supreet Kaur, Erin Kaser, Victor Mendiola, Vanessa Velazquez, Gabriel Giraldo, Qianqian Liu, Joel Michalek, Adolfo Diaz Duque

Blood (2025) 146 (Supplement 1): 2628.

https://doi.org/10.1182/blood-2025-2628

Published: 2025

Journal Articles

A tale of two settings: Survival disparities in CLL/SLL between academic and community cancer programs in the u.S. national cancer database

William Ciurylo, Supreet Kaur, Eleftheria Atalla, Aymen Baig, Oscar Hinojosa Castro, Erin Christine Kaser, Victor Mendiola, Ysaith Orellana Ascencio, Laura Reyes-Uribe, Daniel Rosas, Ahmed Sandu, Esteban Toro Velez, Vanessa Velazquez, Carolina Velez-Mejia, Nikki Verma, Joel Michalek, Qianqian Liu, Leyla Bojanini Molina, Adolfo Diaz Duque

Blood (2025) 146 (Supplement 1): 4403.

https://doi.org/10.1182/blood-2025-4403

Published: 2025

Journal Articles

Real-world survival trends in smoldering versus symptomatic multiple myeloma: A SEER analysis, 2012–2020

Manzer Ali, Bolivia Fernandes, Rajesh Thirumaran, Kirti Arora, Hanzala Jehangir, Aftab Ahmed, Mohammed AL-Jumayli, Daniel Rosas, Muhammad Awais Bin Abdul Malik, Kevin Bera, Jamal Abdul Nasir, Rameen Nadeem Nadeem

Blood (2025) 146 (Supplement 1): 8127.

https://doi.org/10.1182/blood-2025-8127

Published: 2025

Journal Articles

Outcomes of primary cutaneous anaplastic large cell lymphoma across u.S. cancer care settings: A national cancer database analysis.

Victor Mendiola, Leyla Bojanini, Erin Kaser, Daniel Rosas, Vanessa Velazquez, Gabriel Giraldo, Qianqian Liu, Joel Michalek, Supreet Kaur, Adolfo Diaz Duque

Blood (2025) 146 (Supplement 1): 5419.

https://doi.org/10.1182/blood-2025-5419

Published: 2025

Journal Articles

Comparative outcomes of 14,650 patients with mycosis fungoides/Sézary syndrome from academic and community cancer programs

Erin Kaser, Leyla Bojanini, Vanessa Velazquez, Gabriel Giraldo, Victor Mendiola, Daniel Rosas, Supreet Kaur, Qianqian Liu, Joel Michalek, Adolfo Diaz Duque

Blood (2025) 146 (Supplement 1): 5416.

https://doi.org/10.1182/blood-2025-5416

Published: 2025

Journal Articles

Facility-level disparities in outcomes of subcutaneous panniculitis-like T-cell lymphoma: A national cancer database analysis

Gabriel Giraldo Ospino, Leyla Bojanini, Erin Kaser, Victor Mendiola, Vanessa Velazquez, Daniel Rosas, Qianqian Liu, Joel Michalek, Supreet Kaur, Adolfo Diaz Duque

Blood (2025) 146 (Supplement 1): 8023.

https://doi.org/10.1182/blood-2025-8023

Published: 2025

Journal Articles

Early detection of emerging safety signals in GVHD prophylaxis agents using a 12-year faers “slope-watch” approach

Manzer Ali, Bolivia Fernandes, Rajesh Thirumaran, Hanzala Jehangir, Mohammed AL-Jumayli, Aftab Ahmed, Daniel Rosas, Muhammad Awais Bin Abdul Malik, Kirti Arora, Kevin Bera, Jamal Abdul Nasir, Arbaz Hassan

Blood (2025) 146 (Supplement 1): 7767.

https://doi.org/10.1182/blood-2025-7767

Published: 2025

Journal Articles

Early versus late onset hematologic immune‐related adverse events following immune checkpoint inhibition: Temporal patterns, clinical profiles, and risk stratification in faers reports (2014–2025)

Aftab Ahmed, Manzer Ali, Rajesh Thirumaran, Hanzala Jehangir, Mohammed AL-Jumayli, Kirti Arora, Kevin Bera, Daniel Rosas, Muhammad Awais Bin Abdul Malik, Bolivia Fernandes, Muhammad Umer Javaid, Muhammad Arham

Blood (2025) 146 (Supplement 1): 7659.

https://doi.org/10.1182/blood-2025-7659

Published: 2025

Journal Articles

Early post-marketing safety signals of CRISPR-edited exagamglogene autotemcel (Casgevy) versus lentiviral betibeglogene autotemcel (Zynteglo): A faers disproportionality study, 2014–2025

Aftab Ahmed, Rajesh Thirumaran, Manzer Ali, Hanzala Jehangir, Daniel Rosas, Jaison Lawrence Alexander Santhi, Muhammad Awais Bin Abdul Malik, Kevin Bera, Mohammed AL-Jumayli, Kirti Arora, Bolivia Fernandes, Muhammad Umer Javaid, Muhammad Arham

Blood (2025) 146 (Supplement 1): 7838.

https://doi.org/10.1182/blood-2025-7838

Published: 2025

Journal Articles

Facility-level variation in hepatosplenic T-cell lymphoma care: Comparative outcomes from academic and community cancer centers

Daniel Rosas, Leyla Bojanini, Supreet Kaur, Erin Kaser, Victor Mendiola, Vanessa Velazquez, Gabriel Giraldo, Qianqian Liu, Joel Michalek, Adolfo Diaz Duque

Blood (2025) 146 (Supplement 1): 3638.

https://doi.org/10.1182/blood-2025-3638

Published: 2025

Journal Articles

Signal-rich and signal-poor: Divergent detection of early bacterial sepsis and latent viral complications after hematopoietic stem cell transplantation in the FDA adverse event reporting system

Manzer Ali, Bolivia Fernandes, Rajesh Thirumaran, Hanzala Jehangir, Kirti Arora, Kevin Bera, Daniel Rosas, Muhammad Awais Bin Abdul Malik, Aftab Ahmed, Mohammed AL-Jumayli, Jamal Abdul Nasir, Rameen Nadeem Nadeem

Blood (2025) 146 (Supplement 1): 2509.

https://doi.org/10.1182/blood-2025-2509

Published: 2025

Journal Articles

Evolving prognostic impact of B symptoms in non-Hodgkin lymphoma: A competing-risks analysis of SEER data, 2010–2019

Manzer Ali, Saad Rashid, Rajesh Thirumaran, Mohammed AL-Jumayli, Daniel Rosas, Muhammad Awais Bin Abdul Malik, Kevin Bera, Aftab Ahmed, Bolivia Fernandes, Hanzala Jehangir, Kirti Arora

Blood (2025) 146 (Supplement 1): 8047.

https://doi.org/10.1182/blood-2025-8047

Published: 2025

Journal Articles

A national analysis on ALK+ anaplastic large cell lymphomas: Community-based care linked to similar survival outcomes compared to academic centers.

Victor Mendiola, Leyla Bojanini, Erin Kaser, Daniel Rosas, Vanessa Velazquez, Gabriel Giraldo, Qianqian Liu, Joel Michalek, Supreet Kaur, Adolfo Diaz Duque

Blood (2025) 146 (Supplement 1): 3642.

https://doi.org/10.1182/blood-2025-3642

Published: 2025

Journal Articles

Changing patterns and comparative outcomes of “watch-and-wait” versus immediate therapy in CLL: A propensity-weighted SEER analysis, 2000–2020

Manzer Ali, Kashish Magnani, Saad Rashid, Daniel Rosas, Muhammad Awais Bin Abdul Malik, Rajesh Thirumaran, Kevin Bera, Hanzala Jehangir, Mohammed AL-Jumayli, Aftab Ahmed, Kirti Arora, Bolivia Fernandes, Jamal Abdul Nasir

Blood (2025) 146 (Supplement 1): 8069.

https://doi.org/10.1182/blood-2025-8069

Published: 2025

Journal Articles

Comparative suicide risk in hematologic versus solid organ malignancies: A SEER-based competing-risks and cause-specific analysis of 7.4 million reports

Aftab Ahmed, Manzer Ali, Rajesh Thirumaran, Mohammed AL-Jumayli, Hanzala Jehangir, Kirti Arora, Kevin Bera, Daniel Rosas, Muhammad Awais Bin Abdul Malik, Bolivia Fernandes, Muhammad Umer Javaid

Blood (2025) 146 (Supplement 1): 8096.

https://doi.org/10.1182/blood-2025-8096

Published: 2025

Journal Articles

Bleed-versus-clot paradox under immune-checkpoint inhibition: A decade-long US faers analysis reveals divergent class-specific hemostatic phenotypes

Manzer Ali, Bolivia Fernandes, Kirti Arora, Rajesh Thirumaran, Hanzala Jehangir, Mohammed AL-Jumayli, Daniel Rosas, Muhammad Awais Bin Abdul Malik, Kevin Bera, Aftab Ahmed, Jamal Abdul Nasir, Arbaz Hassan

Blood (2025) 146 (Supplement 1): 1313.

https://doi.org/10.1182/blood-2025-1313

Published: 2025

Journal Articles

Comparative outcomes of adult T-cell leukemia/lymphoma in academic and community cancer programs

Erin Kaser, Leyla Bojanini, Vanessa Velazquez, Daniel Rosas, Victor Mendiola, Gabriel Giraldo, Supreet Kaur, Qianqian Liu, Joel Michalek, Adolfo Diaz Duque

Blood (2025) 146 (Supplement 1): 1862.

https://doi.org/10.1182/blood-2025-1862

Published: 2025

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Improved survival outcomes in angioimmunoblastic T-cell lymphoma linked to care at academic cancer centers: A national cancer database study.

Facility type and survival outcomes in extranodal NK/T-cell lymphoma, nasal type: A national cancer database analysis

Cardiovascular safety profile of CD20 × CD3 bispecific antibodies compared to immune-checkpoint inhibitors: A faers analysis, 2014–2025

A national lens on follicular lymphoma: Academic care linked to improved survival in 158,000 patients

A tale of two settings: Survival disparities in CLL/SLL between academic and community cancer programs in the u.S. national cancer database

Real-world survival trends in smoldering versus symptomatic multiple myeloma: A SEER analysis, 2012–2020

Outcomes of primary cutaneous anaplastic large cell lymphoma across u.S. cancer care settings: A national cancer database analysis.

Comparative outcomes of 14,650 patients with mycosis fungoides/Sézary syndrome from academic and community cancer programs

Facility-level disparities in outcomes of subcutaneous panniculitis-like T-cell lymphoma: A national cancer database analysis

Early detection of emerging safety signals in GVHD prophylaxis agents using a 12-year faers “slope-watch” approach

Early versus late onset hematologic immune‐related adverse events following immune checkpoint inhibition: Temporal patterns, clinical profiles, and risk stratification in faers reports (2014–2025)

Early post-marketing safety signals of CRISPR-edited exagamglogene autotemcel (Casgevy) versus lentiviral betibeglogene autotemcel (Zynteglo): A faers disproportionality study, 2014–2025

Facility-level variation in hepatosplenic T-cell lymphoma care: Comparative outcomes from academic and community cancer centers

Signal-rich and signal-poor: Divergent detection of early bacterial sepsis and latent viral complications after hematopoietic stem cell transplantation in the FDA adverse event reporting system

Evolving prognostic impact of B symptoms in non-Hodgkin lymphoma: A competing-risks analysis of SEER data, 2010–2019

A national analysis on ALK+ anaplastic large cell lymphomas: Community-based care linked to similar survival outcomes compared to academic centers.

Changing patterns and comparative outcomes of “watch-and-wait” versus immediate therapy in CLL: A propensity-weighted SEER analysis, 2000–2020

Comparative suicide risk in hematologic versus solid organ malignancies: A SEER-based competing-risks and cause-specific analysis of 7.4 million reports

Bleed-versus-clot paradox under immune-checkpoint inhibition: A decade-long US faers analysis reveals divergent class-specific hemostatic phenotypes

Comparative outcomes of adult T-cell leukemia/lymphoma in academic and community cancer programs

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only